Biotechnology Sector
Drug cocktail boosts ovarian cancer survival time
Jun 02, 2012 14:25 EDT
A drug cocktail that combines chemotherapy with Avastin was shown to double the amount of time patients lived without progression of ovarian cancer, according to research released Saturday.
India's Piramal to buy US firm DRG for $635 mln
May 16, 2012 15:07 EDT
Indian drugmaker Piramal Healthcare on Wednesday said it will buy US-based health data provider Decision Resources Group for $635 million to boost its presence in research and consulting.
Sagan retains lead at Tour of California
May 14, 2012 21:13 EDT
Peter Sagan survived a 10-cyclist crash to retain the overall lead after the second stage of the Amgen Tour of California.
Indian expert panel to probe drugs regulator
May 11, 2012 12:05 EDT
India's Health Ministry said Friday it had set up an expert panel to review the operations of its drug regulatory agency, accused of colluding with pharmaceutical firms to approve drugs without trials.
US experts urge approval of first AIDS prevention pill
May 10, 2012 20:03 EDT
US health advisors on Thursday urged regulators to approve Truvada, made by Gilead Sciences, as the first preventive pill against HIV/AIDS instead of just as a treatment for infected people.
US experts back first AIDS prevention drug
May 10, 2012 19:16 EDT
A US advisory panel on Thursday urged US regulators to approve Truvada by Gilead Sciences as the first pill for prevention of human immunodeficiency virus (HIV).
India probes charges of violations by drugs regulator
May 10, 2012 14:40 EDT
India's Health Ministry said Thursday it was examining charges that the government's top drug regulatory agency had colluded with pharmaceutical firms to approve drugs without proper clinical trials.
US health advisors mull AIDS prevention pill
May 10, 2012 11:17 EDT
US health advisors are poised to decide Thursday on whether to recommend the drug, Truvada, as the first preventive pill against AIDS instead of just a treatment for infected people.
FDA panel urges approval for Pfizer arthritis drug
May 09, 2012 15:01 EDT
An advisory committee to the US Food and Drug Administration on Wednesday urged US regulators to approve a new treatment for rheumatoid arthritis made by the pharmaceutical giant Pfizer.
India's Ranbaxy profit soars on anti-cholesterol drug
May 09, 2012 13:47 EDT
Indian pharmaceutical giant Ranbaxy on Wednesday reported quarterly net profit jumped more than four-fold on-year as performance was boosted by sales of its new copycat cholesterol-busting drug.
GSK launches hostile $2.6 bn bid for research firm
May 09, 2012 08:25 EDT
British drugmaker GlaxoSmithKline on Wednesday said it had gone hostile over its $2.6 billion (2.0 billion-euro) takeover bid for US research partner Human Genome Sciences Inc.
GSK's hostile $2.6 bn bid for Human Genome Sciences
May 09, 2012 04:51 EDT
British drugmaker GlaxoSmithKline on Wednesday said it had gone hostile over its $2.6 billion (2.0 billion-euro) takeover bid for US research partner Human Genome Sciences Inc.
Abbott Labs fined $1.6 bn over drug marketing
May 07, 2012 18:21 EDT
Drugmaker Abbott Laboratories has been fined $1.6 billion for marketing its anti-seizure medication Depakote for other unauthorized uses, US authorities and the company announced Monday.
Bayer challenges India cancer drug ruling
May 05, 2012 11:58 EDT
German pharmaceutical giant Bayer AG has challenged a ground-breaking Indian ruling that allowed a local firm to produce a vastly cheaper copy of its patented drug for kidney and liver cancer.
Indian drug giant Cipla slashes cancer drug prices
May 04, 2012 12:39 EDT
Indian generic drug giant Cipla said Friday it had slashed by up to 76 percent prices of three anti-cancer medicines in what it called a "humanitarian" move and promised to cut the costs of more products.
London shares rise, lifted by company results
Apr 26, 2012 12:20 EDT
London shares closed higher on Thursday, boosted by strong corporate results, traders said.
Bayer Q1 profit jumps by half
Apr 26, 2012 05:33 EDT
German chemicals and pharmaceuticals giant Bayer, maker of Aspirin, said Thursday it was "increasingly confident" for its business this year after a good start to 2012.
AstraZeneca boss to retire as profits tumble
Apr 26, 2012 04:52 EDT
Anglo-Swedish pharmaceuticals giant AstraZeneca said Thursday that net profits nosedived by 44 percent in the first quarter and announced the exit of chief executive David Brennan.
Bayer says profits up 54% in first quarter
Apr 26, 2012 02:23 EDT
German chemicals and pharmaceuticals giant Bayer, maker of Aspirin, said Thursday it got off to an "encouraging start" to 2012 with net profit soaring 53.5 percent in the first three months.
Watson to buy Actavis, creating generics giant
Apr 25, 2012 19:40 EDT
US drug maker Watson Pharmaceuticals said Wednesday it will buy Iceland-based Actavis for 4.25 billion euros ($5.62 billion), creating the world's third-largest generic drugs company.
